Atlas Capital Advisors’s Genmab GMAB Stock Holding History

Atlas Capital Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.9K	Hold	189	–	–	﹤0.01%	830
2025 Q1	$3.7K	Hold	189	–	–	﹤0.01%	871
2024 Q4	$3.94K	Hold	189	–	–	﹤0.01%	836
2024 Q3	$4.61K	Hold	189	–	–	﹤0.01%	783
2024 Q2	$4.75K	Hold	189	–	–	﹤0.01%	784
2024 Q1	$5.65K	Hold	189	–	–	﹤0.01%	758
2023 Q4	$6.02K	Hold	189	–	–	﹤0.01%	781
2023 Q3	$6.67K	Hold	189	–	–	﹤0.01%	745
2023 Q2	$7.18K	Hold	189	–	–	﹤0.01%	763
2023 Q1	$7.14K	Sell	189 -2,299	-92%	-$88.4K	﹤0.01%	766
2022 Q4	$105K	Buy	2,488 +1,588	+176%	+$65.4K	0.02%	441
2022 Q3	$28.9K	Buy	+900	New	+$31.6K	0.01%	609
2022 Q2	–	Sell	-900	Closed	-$32.6K	–	992
2022 Q1	$32.6K	Hold	900	–	–	0.01%	588
2021 Q4	$35.6K	Hold	900	–	–	0.01%	568
2021 Q3	$39.3K	Hold	900	–	–	0.01%	550
2021 Q2	$36.7K	Hold	900	–	–	0.01%	566
2021 Q1	$29.5K	Hold	900	–	–	0.01%	549
2020 Q4	$36.6K	Buy	+900	New	+$33.6K	0.01%	491

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Atlas Capital Advisors's GMAB Position: Q2 2025 in Review

Atlas Capital Advisors held its Genmab (GMAB) position steady in Q2 2025 at 189 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Atlas Capital Advisors first reported a position in GMAB in Q4 2020 and has held it in 18 quarters since. The position peaked at $105K in Q4 2022. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

Atlas Capital Advisors held 189 shares of Genmab worth $3.9K as of Q2 2025.
Atlas Capital Advisors left its Genmab share count unchanged in Q2 2025.
Genmab made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2025, its #830 holding.
Atlas Capital Advisors first reported a position in Genmab in Q4 2020 and has held it in 18 quarters since.
Atlas Capital Advisors's Genmab position peaked at $105K in Q4 2022.
217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Atlas Capital Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.